CH‐Directed Anion–π Interactions in the Crystals of Pentafluorobenzyl‐Substituted Ammonium and Pyridinium Salts

Simple pentafluorobenzyl‐substituted ammonium and pyridinium salts with different anions can be easily obtained by treatment of the parent amine or pyridine with the respective pentafluorobenzyl halide. Hexafluorophosphate is introduced as the anion by salt metathesis. In the case of the ammonium salt 4 , water co‐crystallisation seems to suppress effective anion–π interactions of bromide with the electron‐deficient aromatic system, whereas with salts 5 and 6 such interactions are observed despite the presence of water. However, due to asymmetric hydrogen‐bonding interactions with ammonium side chains, the anion of 5 is located close to the rim of the pentafluorophenyl group (η¹ interaction). In 6 the CH–anion hydrogen bonding is more symmetric and fixes the anion on top of the ring (η⁶). A similar structure‐controlling effect is observed in case of the 1,4‐diazabicyclo[2.2.2]octane derivatives 7 . Here the position of the anion (Cl, Br, I) is shifted according to the length of the weak CH–halide interaction. The hexafluorophosphate 7 d reveals that this “non‐coordinating” anion can be located on top of an aromatic π system. In the methyl‐substituted pyridinium salts 9 and 10 different locations of the bromide anions with respect to the π system are observed. This is due to different conformations of the mono‐ versus disubstituted pyridine, which leads to different directions of the weak, but structurally important, H_Me? Br bonds.     

New In Vitro-In Silico Approach for the Prediction of In Vivo Performance of Drug Combinations

Pharmacokinetic (PK) studies improve the design of dosing regimens in preclinical and clinical settings. In complex diseases like cancer, single-agent approaches are often insufficient for an effective treatment, and drug combination therapies can be implemented. In this work, in silico PK models were developed based on in vitro assays results, with the goal of predicting the in vivo performance of drug combinations in the context of cancer therapy. Combinations of reference drugs for cancer treatment, gemcitabine and 5-fluorouracil (5-FU), and repurposed drugs itraconazole, verapamil or tacrine, were evaluated in vitro. Then, two-compartment PK models were developed based on the previous in vitro studies and on the PK profile reported in the literature for human patients. Considering the quantification parameter area under the dose-response-time curve (AUC_effect) for the combinations effect, itraconazole was the most effective in combination with either reference anticancer drugs. In addition, cell growth inhibition was itraconazole-dose dependent and an increase in effect was predicted if itraconazole administration was continued (24-h dosing interval). This work demonstrates that in silico methods and AUC_effect are powerful tools to study relationships between tissue drug concentration and the percentage of cell growth inhibition over time.     

An Errata to: Convergence of a SOR-Weiszfeld Type Algorithm for Incomplete Data Sets

We discovered an error in our proof of convergence of a generalization of the Weiszfeld algorithm to incomplete data sets, and we provide here a partial correction, with slightly weaker claims.     

Experimental and theoretical investigations of tellurium(IV) diimides and imidotelluroxanes: X-ray structures of B(C6F5)3 adducts of OTe(mu-NtBu)2TeNtBu, [OTe(mu-NtBu)2Te(mu-O)]2 and tBuNH2

The hydrolysis of (t)BuNTe(mu-N(t)Bu)(2)TeN(t)Bu (1) with 1 or 2 equiv of (C(6)F(5))(3)B.H(2)O results in the successive replacement of terminal imido groups by oxo ligands to give the telluroxane-Lewis acid adducts (C(6)F(5))(3)B.OTe(mu-N(t)Bu)(2)TeN(t)Bu (2) and [(C(6)F(5))(3)B.OTe(mu-N(t)Bu)(2)Te(mu-O)](2) (3), which were characterized by multinuclear NMR spectroscopy and X-ray crystallography. The Te=O distance in 2 is 1.870(2) A. The di-adduct 3 involves the association of four (t)()BuNTeO monomers to give a tetramer in which both terminal Te=O groups [d(TeO) = 1.866(3) A] are coordinated to B(C(6)F(5))(3). The central Te(2)O(2) ring in 3 is distinctly unsymmetrical [d(TeO) = 1.912(3) and 2.088(2) A]. The X-ray structure of (C(6)F(5))(3)B.NH(2)(t)()Bu (4), the byproduct of these hydrolysis reactions, is also reported. The geometries and energies of tellurium(IV) diimides and imido telluroxanes were determined using quantum chemical calculations. The calculated energies for the reactions E(NR)(2) + Te(NR)(2) (E = S, Se, Te; R = H, Me, (t)Bu, SiMe(3)) confirm that cyclodimerization of tellurium(IV) diimides is strongly exothermic. In the mixed-chalcogen systems, the cycloaddition is energetically favorable for the Se/Te combination. The calculated energies for the further oligomerization of the dimers XE(mu-NMe)(2)EX (E = Se, Te; X = NMe, O) indicate that the formation of tetramers is strongly exothermic for the tellurium systems but endothermic (X = NMe) or thermoneutral (X = O) for the selenium systems, consistent with experimental observations.     

Selective recognition of aromatic hydrocarbons by endo-functionalized molecular tubes via C/N-H…π interactions

Aromatic hydrocarbons can be selectively recognized by four endo-functionalized molecular tubes through C/N-H...π interactions in nonpolar media with binding constants up to 1580 L/mol.     

Copolymerization of vinylcyclohexane with ethene and propene using zirconocene catalysts

Vinylcyclohexane (VCH) was copolymerized with ethene and propene using methylaluminoxane‐activated metallocene catalysts. The catalyst precursor for the ethene copolymerization was rac‐ethylenebis(indenyl)ZrCl₂ ( 1 ). Propene copolymerizations were further studied with C_s‐symmetric isopropylidene(cyclopentadienyl)(fluorenyl)ZrCl₂ ( 2 ), C₁‐symmetric ethylene(1‐indenyl‐2‐phenyl‐2‐fluorenyl)ZrCl₂ ( 3 ), and “meso”‐dimethylsilyl[3‐benzylindenyl)(2‐methylbenz[e]indenyl)]ZrCl₂ ( 4 ). Catalyst 1 produced a random ethene–VCH copolymer with very high activity and moderate VCH incorporation. The highest comonomer content in the copolymer was 3.5 mol %. Catalysts 1 and 4 produced poly(propene‐co‐vinylcyclohexane) with moderate to good activities [up to 4900 and 15,400 kg of polymer/(mol of catalyst × h) for 1 and 4 , respectively] under similar reaction conditions but with fairly low comonomer contents (up to 1.0 and 2.0% for 1 and 4 , respectively). Catalysts 2 and 3 , both bearing a fluorenyl moiety, gave propene–VCH copolymers with only negligible amounts of the comonomer. The homopolymerization of VCH was performed with 1 as a reference, and low‐molar‐mass isotactic polyvinylcyclohexane with a low activity was obtained. © 2006 Wiley Periodicals, Inc. J Polym Sci Part A: Polym Chem 44: 6569–6574, 2006